MedPath

Adaptive Arm Training for Children With Hemiplegia

Not Applicable
Conditions
Hemiplegia
Acquired Brain Injury
Cerebral Palsy
Hemiparesis
Registration Number
NCT03387449
Lead Sponsor
Blythedale Children's Hospital
Brief Summary

The goal of this research is to provide limb training in children with hemiplegia using a bimanual-to-unimanual training approach. Twenty pediatric patients aged 5-17 years with acquired brain injury will receive training on the bimanual-to-unimanual device for a period of 9 weeks. During the training, children use both arms to operate robotic arms to play a video game. We will assess changes in hand impairment after the training.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
20
Inclusion Criteria
  • Hemiplegia due to brain injury at least 3 months before study enrollment.
Exclusion Criteria
  • Any social or medical problem that precludes compliance with the protocol.
  • Treatment with botulinum toxin or intrathecal baclofen in the 3 months preceding enrollment.
  • Implanted neuromodulatory or electronic device or other complicating illness.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Change in Box and Box TestBefore intervention compared to after intervention

The Box and Blocks test measures how many blocks a child can move with one hand from one box to another in one minute with the impaired hand.

Change in Assisting Hand AssessmentBefore intervention compared to after intervention

The Assisting Hand Assessment evaluated how effectively children use their hands to complete bimanual tasks.

Change in range of motionBefore intervention compared to after intervention

The robotic device measures range of motion of the shoulder.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Kathleen M Friel

🇺🇸

Hartsdale, New York, United States

Kathleen M Friel
🇺🇸Hartsdale, New York, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.